ISS Stage I Plasma Cell Myeloma
1 clinical trials · Condition
◉ Watch ISS Stage I Plasma Cell Myeloma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma (NCT03267888) | Emory University | 2018-05-29 |
Track ISS Stage I Plasma Cell Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.